Menlo Therapeutics Inc. (MNLO) can’t be written off after posting last 3-months Average volume of 5.41M

Let’s start up with the current stock price of Menlo Therapeutics Inc. (MNLO), which is $1.68 to be very precise. The Stock rose vividly during the last session to $1.73 after opening rate of $1.69 while the lowest price it went was recorded $1.62 before closing at $1.69.

Recently in News on June 5, 2020, Menlo Therapeutics Announces Pricing of Offering of Common Stock. Menlo Therapeutics Inc. (“Menlo”) (MNLO), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced the pricing of an underwritten public offering of 27,050,000 shares of common stock at a price to the public of $1.85 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be $50,042,500, excluding any exercise of the underwriters’ option to purchase additional shares. All of the shares of common stock to be sold in the offering will be offered by Menlo. In addition, Menlo has granted the underwriters a 30-day option to purchase up to an additional 4,057,500 shares of its common stock. The offering is expected to close on June 9, 2020, subject to customary closing conditions. You can read further details here

Menlo Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $7.4800 on 01/17/20, with the lowest value was $1.0000 for the same time period, recorded on 04/08/20.

Menlo Therapeutics Inc. (MNLO) full year performance was -66.06%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Menlo Therapeutics Inc. shares are logging -77.47% during the 52-week period from high price, and 68.50% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.00 and $7.48.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 921426 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Menlo Therapeutics Inc. (MNLO) recorded performance in the market was -63.58%, having the revenues showcasing 59.43% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 290.00M, as it employees total of 180 workers.

The Analysts eye on Menlo Therapeutics Inc. (MNLO)

According to the data provided on, the moving average of the company in the 100-day period was set at 2.3091, with a change in the price was noted -3.6350. In a similar fashion, Menlo Therapeutics Inc. posted a movement of -68.07% for the period of last 100 days, recording 3,934,333 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for MNLO is recording 0.47 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.47.

Technical rundown of Menlo Therapeutics Inc. (MNLO)

Raw Stochastic average of Menlo Therapeutics Inc. in the period of last 50 days is set at 20.61%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 11.33%. In the last 20 days, the company’s Stochastic %K was 10.44% and its Stochastic %D was recorded 10.59%.

Considering, the past performance of Menlo Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -63.58%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -66.53%, alongside a downfall of -66.06% for the period of the last 12 months. The shares increased approximately by -2.31% in the 7-day charts and went up by -19.14% in the period of the last 30 days. Common stock shares were driven by 59.43% during last recorded quarter.